Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Medtronic (MDT) and Astria Therapeutics (ATXS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC – Research Report), Medtronic (MDT – Research Report) and Astria Therapeutics (ATXS – Research Report).

Teladoc (TDOC)

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Teladoc today and set a price target of $26.00. The company’s shares closed last Tuesday at $20.49.

According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 16.1% and a 69.2% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Community Health, The Ensign Group, and HCA Healthcare.

Currently, the analyst consensus on Teladoc is a Moderate Buy with an average price target of $22.55, an 9.0% upside from current levels. In a report released yesterday, RBC Capital also maintained a Buy rating on the stock with a $25.00 price target.

See today’s best-performing stocks on TipRanks >>

Medtronic (MDT)

In a report released today, Steven Lichtman from Oppenheimer maintained a Hold rating on Medtronic, with a price target of $92.00. The company’s shares closed last Tuesday at $85.85.

According to TipRanks.com, Lichtman is a 5-star analyst with an average return of 12.1% and a 52.5% success rate. Lichtman covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, Boston Scientific, and AngioDynamics.

Currently, the analyst consensus on Medtronic is a Moderate Buy with an average price target of $93.40, representing a 7.4% upside. In a report released yesterday, J.P. Morgan also maintained a Hold rating on the stock.

Astria Therapeutics (ATXS)

In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Astria Therapeutics, with a price target of $25.00. The company’s shares closed last Tuesday at $13.95, close to its 52-week high of $15.65.

According to TipRanks.com, Singh is a 5-star analyst with an average return of 15.1% and a 45.8% success rate. Singh covers the Healthcare sector, focusing on stocks such as Entrada Therapeutics Inc, Vertex Pharmaceuticals, and Inovio Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Astria Therapeutics with a $19.25 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on TDOC:

• Teladoc Inc. Earnings Update: Did it Beat Estimate Forecasts?
• Teladoc (NYSE:TDOC) Delivers Mixed Q4, Stock Drops On Downbeat Outlook
• Teladoc Health Reports Fourth Quarter and Full Year 2023 Results
• Options Volatility and Implied Earnings Moves Today, February 20, 2024
• Teladoc Health Provides Updated Start Time for Fourth Quarter 2023 Earnings Call on February 20, 2024